Deciphering neurological symptoms in ANCA-associated vasculitis, uncontrolled disease or a complication of therapy

Rheumatology key messagesWithdrawing and withholding further immunosuppression in AAV patients with PML can result in a better- than-expected outcome.Mirtazipine can be considered to facilitate PML control.PML can occur after rituximab (and other immunosuppressants) in AAV patients but may be less common than in SLE patients treated with rituximab.
Source: Rheumatology - Category: Rheumatology Source Type: research